NO990157L - Granulater av heksahydropyrazinderivater som kan bli administrert oralt - Google Patents

Granulater av heksahydropyrazinderivater som kan bli administrert oralt

Info

Publication number
NO990157L
NO990157L NO990157A NO990157A NO990157L NO 990157 L NO990157 L NO 990157L NO 990157 A NO990157 A NO 990157A NO 990157 A NO990157 A NO 990157A NO 990157 L NO990157 L NO 990157L
Authority
NO
Norway
Prior art keywords
granules
administered orally
hexahydropyrazine derivatives
hexahydropyrazine
derivatives
Prior art date
Application number
NO990157A
Other languages
English (en)
Other versions
NO990157D0 (no
NO325272B1 (no
Inventor
Jochen Kalbe
Terence Hopkins
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO990157D0 publication Critical patent/NO990157D0/no
Publication of NO990157L publication Critical patent/NO990157L/no
Publication of NO325272B1 publication Critical patent/NO325272B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19990157A 1996-07-17 1999-01-14 Fremgangsmate for fremstilling av oralt administrerbare formuleringer av heksahydropyrazinderivater samt granulater inneholdende slike derivater NO325272B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19628776A DE19628776A1 (de) 1996-07-17 1996-07-17 Oral applizierbare Granulate von Hexahydropyrazinderivaten
PCT/EP1997/003537 WO1998003157A1 (de) 1996-07-17 1997-07-04 Oral applizierbare granulate von hexahydropyrazinderivaten

Publications (3)

Publication Number Publication Date
NO990157D0 NO990157D0 (no) 1999-01-14
NO990157L true NO990157L (no) 1999-01-14
NO325272B1 NO325272B1 (no) 2008-03-17

Family

ID=7800044

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990157A NO325272B1 (no) 1996-07-17 1999-01-14 Fremgangsmate for fremstilling av oralt administrerbare formuleringer av heksahydropyrazinderivater samt granulater inneholdende slike derivater

Country Status (17)

Country Link
US (1) US6503536B2 (no)
EP (1) EP0912167B1 (no)
JP (1) JP4202422B2 (no)
KR (1) KR100485149B1 (no)
CN (1) CN1225579A (no)
AT (1) ATE227565T1 (no)
AU (1) AU711705B2 (no)
BR (1) BR9710377B1 (no)
CA (1) CA2260889C (no)
DE (2) DE19628776A1 (no)
DK (1) DK0912167T3 (no)
ES (1) ES2183200T3 (no)
HU (1) HUP9903180A3 (no)
NO (1) NO325272B1 (no)
NZ (1) NZ333745A (no)
PT (1) PT912167E (no)
WO (1) WO1998003157A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1531680A1 (en) * 2002-08-13 2005-05-25 Akzo Nobel Compositions and process for delivering an additive
US20040180034A1 (en) * 2003-03-10 2004-09-16 Lyn Hughes Anthelmintic resinates and a method for their preparation
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
CN104168900A (zh) 2012-02-06 2014-11-26 梅里亚有限公司 包含全身性地起作用的活性剂的杀寄生虫口服兽用组合物、方法及其用途
BR112014024833B1 (pt) 2012-04-04 2022-10-04 Intervet International B.V. Produto farmacêutico veterinário mastigável macio, processo para sua fabricação e seu uso, bem como uso de pamoato de sódio

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4447414A (en) * 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics
DE3472678D1 (de) 1983-07-18 1988-08-18 Beecham Group Plc Benzazepine and benzoxazepine derivatives
DE3623321A1 (de) * 1986-07-11 1988-01-21 Bayer Ag Verfahren zur kontinuierlichen herstellung von sphaerischen granulaten
FI101344B1 (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
CN1099973A (zh) * 1993-09-08 1995-03-15 四川省医学科学院寄生虫病防治研究所 兽用驱虫药物复方制剂
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations

Also Published As

Publication number Publication date
ES2183200T3 (es) 2003-03-16
HUP9903180A3 (en) 2000-07-28
JP2000515519A (ja) 2000-11-21
WO1998003157A1 (de) 1998-01-29
KR100485149B1 (ko) 2005-04-25
NO990157D0 (no) 1999-01-14
KR20000067862A (ko) 2000-11-25
DE19628776A1 (de) 1998-01-22
ATE227565T1 (de) 2002-11-15
EP0912167A1 (de) 1999-05-06
PT912167E (pt) 2003-03-31
AU711705B2 (en) 1999-10-21
US6503536B2 (en) 2003-01-07
EP0912167B1 (de) 2002-11-13
BR9710377A (pt) 1999-08-17
JP4202422B2 (ja) 2008-12-24
US20010055598A1 (en) 2001-12-27
CA2260889A1 (en) 1998-01-29
NO325272B1 (no) 2008-03-17
DK0912167T3 (da) 2003-03-10
HUP9903180A2 (hu) 2000-04-28
NZ333745A (en) 2000-10-27
CA2260889C (en) 2007-09-11
CN1225579A (zh) 1999-08-11
AU3541397A (en) 1998-02-10
DE59708723D1 (de) 2002-12-19
BR9710377B1 (pt) 2011-10-18

Similar Documents

Publication Publication Date Title
EP1283054A4 (en) MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF
NO933028D0 (no) Peg-interferonkonjugater
CA2258217A1 (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
NO990157D0 (no) Granulater av heksahydropyrazinderivater som kan bli administrert oralt
MY117606A (en) Orally administrable formulations of quinolone- or naphthyridonecarboxylic acids
DK0736033T3 (da) Hidtil ukendte terapeutiske carbohydratblandinger, som er nyttige til afhjælpning af præmenstruelt syndrom
KR910018381A (ko) 개선된 에르골린-8-카복스아미드
PT1091740E (pt) Preparacoes aquosas semi-solidas para administracao oral de toltrazuril-sulfona
NO913019L (no) Faste orale preparatformer som inneholder ifosfamid som virksomt stoff.
NO975127L (no) Anvendelse av ikke-steroidale antiinflammatoriske midler for å forbedre den fysiologiske forlikelighet av partikulære farmasöytiske preparater
RU2002113885A (ru) Мазь ибупрофена, приготовленная на полиэтиленоксидной основе, обладающая противовоспалительным действием
BR0107630A (pt) Composição
AU6725300A (en) Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
JPS6456622A (en) Percutaneous absorbefacient base composition
KR910000645A (ko) 개선된 경련치료제
KR910009723A (ko) 4-카르바모일-1-β-D-리보푸라노실 이미다졸륨-5-올레이트 무수결정
JPS5290694A (en) Preparation of protoporphyrine 1x
DK0488044T3 (da) En imidazobenzodiazepin til behandling af søvnforstyrrelser
JPS5325534A (en) Mandelic acid glucosides and their anti-cancerous preparations
JPS5238506A (en) Detergent composition
JPS5248677A (en) Preparation of pyrimidine derivatives
RU99118372A (ru) Антиоксидантная композиция
JPS5325558A (en) Novel pyrrole derivatives and their preparation
JPS5367795A (en) Preparation of microhydrogel

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MM1K Lapsed by not paying the annual fees